Sugammadex ED90 dose to reverse the rocuronium neuromuscular blockade in obese patients.

Objective: to determine the ED90 (minimum effective dose in 90% of patients) of sugammadex for the reversal of rocuronium-induced moderate neuromuscular blockade (NMB) in patients with grade III obesity undergoing bariatric surgery.

Methods: we conducted a prospective study with the biased coin up-and-down sequential design. We chosen the following doses: 2.

[Use of forced-air to prevent intraoperative hypothermia].

Objective: Hypothermia is a life-threatening event during the perioperative period. No consensus has been reached about the best active warming approach for such cases. Furthermore there is no consensus on the most appropriate time to warm a hypothermic patient.

Impact of induced cardiac arrest on cognitive function after implantation of a cardioverter-defibrillator.

Background And Objectives: Implantable cardioverter-defibrillators (ICD) were introduced in clinical practice in 1980 and they are considered the standard treatment for individuals at risk for fatal ventricular arrhythmias. To ensure proper working conditions, the energy necessary to interrupt ventricular tachycardia or ventricular fibrillation should be determined during implantation by a test called defibrillation threshold. For this test, it is necessary to induce ventricular fibrillation, which should be identified and treated by the device.